Skip to main content
. 2023 Jun 14;8(25):22603–22612. doi: 10.1021/acsomega.3c01110

Figure 4.

Figure 4

Kinase inhibitors tested against SARS-CoV-2 in Calu-3 cells. (A) Control: remdesivir, (B) bosutinib, (C) crizotinib, and (D) olmutinib. Sample well data was normalized to DMSO control wells and plotted versus drug concentration to determine the IC50 (infection: blue) and CC50 (toxicity: green). The x axis shows concentrations in a logarithmic scale.